Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.
作者信息
Allen J M, Kerle D J, Ware H, Doble A, Williams G, Bloom S R
出版信息
Br Med J (Clin Res Ed). 1983 Dec 10;287(6407):1766. doi: 10.1136/bmj.287.6407.1766.
Abstract
摘要
相似文献
1
Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.酮康唑与促黄体生成素释放激素类似物联合治疗：一种针对耐药性进展性前列腺癌的新方法。
Br Med J (Clin Res Ed). 1983 Dec 10;287(6407):1766. doi: 10.1136/bmj.287.6407.1766.
2
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.长期使用促黄体生成素释放激素治疗前列腺癌未能抑制血清促黄体生成素和睾酮。
Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):468-9. doi: 10.1136/bmj.289.6443.468.
3
[Hormonal manipulation of disseminated prostatic cancer].
Acta Urol Belg. 1984;52(4):593-9.
4
Prostatic cancer: treatment with long-acting LHRH analogue.
Br J Urol. 1983 Dec;55(6):743-6. doi: 10.1111/j.1464-410x.1983.tb03417.x.
5
[New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Rev Rhum Mal Osteoartic. 1985 Oct;52(10):577-85.
6
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.晚期前列腺癌：用促性腺激素释放激素激动剂治疗
Br Med J (Clin Res Ed). 1983 May 21;286(6378):1607-9. doi: 10.1136/bmj.286.6378.1607.
7
New treatment for prostatic cancer.
Lancet. 1983 Aug 20;2(8347):438.
8
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms.
Lancet. 1983 Aug 20;2(8347):415-9. doi: 10.1016/s0140-6736(83)90387-2.
9
Endocrine therapy: non-estrogenic pharmacological manipulation.
Semin Urol. 1983 Nov;1(4):288-90.
10
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma.促黄体生成素释放激素（LHRH）激动剂ICI 118630在晚期前列腺癌治疗中的潜在疗效。
Lancet. 1983 Aug 20;2(8347):413-5. doi: 10.1016/s0140-6736(83)90386-0.
引用本文的文献
1
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.雄激素合成抑制剂酮康唑和醋酸阿比特龙在去势抵抗性前列腺癌中的序贯使用及循环雄激素的预测价值
Clin Cancer Res. 2014 Dec 15;20(24):6269-76. doi: 10.1158/1078-0432.CCR-14-1595. Epub 2014 Oct 21.
2
Flare Associated with LHRH-Agonist Therapy.与促性腺激素释放激素激动剂治疗相关的 flare
Rev Urol. 2001;3 Suppl 3(Suppl 3):S10-4.
3
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.既往内分泌治疗对单次剂量促性腺激素释放激素类似物反应的影响。
Urol Res. 1984;12(5):249-51. doi: 10.1007/BF00256149.
4
Treatment of advanced carcinoma of the prostate.晚期前列腺癌的治疗。
Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):571-2. doi: 10.1136/bmj.289.6445.571.
5
Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.酮康唑长期治疗急性白血病患者时皮质醇分泌未受抑制。
J Clin Pathol. 1985 Jun;38(6):677-8. doi: 10.1136/jcp.38.6.677.
6
GnRH agonists and antagonists. Current clinical status.促性腺激素释放激素激动剂和拮抗剂。当前临床状况。
Drugs. 1988 Jan;35(1):63-82. doi: 10.2165/00003495-198835010-00004.
7
Hormonal aspects of prostatic cancer: a review.前列腺癌的激素方面：综述
J R Soc Med. 1985 Feb;78(2):129-35. doi: 10.1177/014107688507800212.
8
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.高剂量酮康唑：对绝经后乳腺癌的内分泌及治疗作用
Br J Cancer. 1988 Oct;58(4):493-6. doi: 10.1038/bjc.1988.247.
本文引用的文献
1
Ketoconazole: a novel and rapid treatment for advanced prostatic cancer.
J Urol. 1983 Jul;130(1):152-3. doi: 10.1016/s0022-5347(17)51007-1.
2
Ketoconazole blocks testosterone synthesis.酮康唑可阻断睾酮的合成。
Arch Intern Med. 1982 Nov;142(12):2137-40.
3
Ketoconazole blocks adrenal steroid synthesis.酮康唑可阻断肾上腺类固醇的合成。
Ann Intern Med. 1982 Sep;97(3):370-2. doi: 10.7326/0003-4819-97-3-370.
4
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.晚期前列腺癌：用促性腺激素释放激素激动剂治疗
Br Med J (Clin Res Ed). 1983 May 21;286(6378):1607-9. doi: 10.1136/bmj.286.6378.1607.
Zotero 插件